Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

89 results about "Demethylase" patented technology

Demethylases are enzymes that remove methyl (CH₃-) groups from nucleic acids, proteins (in particular histones), and other molecules. Demethylase enzymes are important in epigenetic modification mechanisms. The demethylase proteins alter transcriptional regulation of the genome by controlling the methylation levels that occur on DNA and histones and, in turn, regulate the chromatin state at specific gene loci within organisms.

Radish bolting and flowering gene RsSUF4 regulated by m6A demethylase and application of radish bolting and flowering gene RsSUF4

The invention discloses a radish bolting and flowering gene RsSUF4 regulated by m6A demethylase and application of the radish bolting and flowering gene RsSUF4, relates to the technical field of bioengineering, and is technically characterized in that the gene is RsSUF4. The functions of the demethylase RsALKBH10B and the flowering inhibition gene RsSUF4 in the flowering process are analyzed in a targeted manner, and a specific association mechanism between m6A modification and radish flowering regulation and control is defined.
Owner:GUIZHOU UNIV

Application of ALKBH2 gene or encoded protein thereof in regulation and control of plant growth or yield

The invention discloses an application of an ALKBH2 gene or an encoded protein thereof in regulation and control of plant growth or yield. The ALKBH2 gene in rice is mutated to obtain the ALKBH2 gene mutant, compared with wild rice, the ALKBH2 gene mutant shows phenotypes such as plant height increase, leaf width increase, tiller number, effective tiller number and hundred-grain weight increase, and the ALKBH2 gene mutant proves that the ALKBH2 gene or the encoded protein thereof has the functions of regulating plant growth or yield and the like. According to the invention, the ALKBH2 gene is further expressed to obtain the ALKBH2 protein, and an enzyme activity experiment proves that the ALKBH2 protein is an m6A demethylase. The invention has application prospects in the aspects of regulating and controlling plant growth, increasing plant yield and the like.
Owner:THE INST OF BIOTECHNOLOGY OF THE CHINESE ACAD OF AGRI SCI

Engineered RNA demethylases for improved plant growth

The present disclosure relates to engineered RNA m6A demethylases with disrupted low complexity regions (LCRs) for expression in plants, as well as recombinant DNA encoding the engineered RNA m6A demethylases, vectors encoding the recombinant DNA, plants including the engineered RNA m6A demethylases, and method of improving the growth of plants using the engineered RNA m6A demethylases, including increased root growth and elevated photosynthesis. The present disclosure further relates to methods of improving growth of a plant, including increased root growth and elevated photosynthesis, by modifying endogenous ALKBH5 homolog genes to include disrupted LCRs, and plants produced by those methods.
Owner:UNIVERSITY OF CHICAGO

ATP (adenosine triphosphate) nucleic acid aptamer based on m6A epigenetic base modification and application of ATP nucleic acid aptamer

The invention belongs to the field of biosensing detection, and particularly relates to an ATP (adenosine triphosphate) nucleic acid aptamer based on m6A epigenetic base modification and application of the ATP nucleic acid aptamer. The invention provides a nucleic acid aptamer and a nucleic acid aptamer sensor. On the basis of recognition and binding specificity of a nucleic acid aptamer probe to a target, a single-point methylation closed switch type functional probe is constructed, and living cell and living body imaging detection of endogenous demethylase is realized. Taking ATP and an aptamer thereof as an example, m6A methylation modifies key sites of the aptamer so as to influence the binding stability between the aptamer and a ligand, after endogenous FTO demethylation, the aptamer recovers active sites, can be rapidly bound with ATP and is driven to allosteric to release fluorescence, and in-situ instant detection of FTO is realized.
Owner:THE SEVENTH AFFILIATED HOSPITAL SUN YAT SEN UNIV SHENZHEN +1

Application and method of wheat demethylase TaALKBH23 in regulation and control of drought stress resistance of plants

The invention discloses application and a method of wheat demethylase TaALKBH23 in regulation and control of drought stress resistance of plants, a coding sequence of the demethylase TaALKBH23 is shown as SEQ ID NO: 1, and an amino acid sequence coded by the demethylase TaALKBH23 is shown as SEQ ID NO: 2. The invention provides demethylase TaALKBH23 and a function and application of a coding gene of the demethylase TaALKBH23 in regulation and control of plant drought resistance, and it is found through construction of a TaALKBH23 wheat genetic transformation material that the gene negatively regulates and controls wheat drought resistance. It is found that TaALKBH23 plays an important role in the process of regulating and controlling drought stress resistance of plants, and a new gene resource is provided for improving drought resistance of crops.
Owner:NORTHWEST A & F UNIV

Demethylase ODM gene for synthesizing benzylisoquinoline alkaloid and application of demethylase ODM gene

The invention discloses a demethylase ODM gene for synthesizing benzylisoquinoline alkaloids and application thereof, the demethylase ODM gene is an ODM1 gene or an ODM2 gene, the nucleotide sequence of the CDS region of the ODM1 gene is shown as SEQ ID NO: 1, and the nucleotide sequence of the CDS region of the ODM2 gene is shown as SEQ ID NO: 2. Aiming at the current situation that the research basis of a key gene for synthesizing corydalmine in rhizoma corydalis is weak, the ODM1 gene for catalyzing tetrahydropalmatine demethylation to specifically generate corydalmine and tetrahydrojatrorrhizine and the ODM2 gene for specifically generating tetrahydrojatrorrhizine are cloned from rhizoma corydalis for the first time. An important theoretical basis is provided for producing the corydalmine by utilizing a synthetic biological method in the future, and the corydalmine mutant has a wide application prospect and a great economic value.
Owner:CHINA PHARM UNIV

Method of controlling wheat septospora resistant to C14-demethylase inhibitor fungicides

The invention relates to a method for controlling wheat septospora which is resistant to a C14-demethylase inhibitor fungicide. The present invention relates to a method for controlling wheat septospora on a cereal plant, which wheat septospora comprises at least one mutation in the CYP51 gene and is resistant to a C14-demethylase (in sterol biosynthesis) inhibitor fungicide (DMI fungicide), the method comprises applying to these plants, seeds or soil of the plants a fungicidally effective amount of (I) methyl 2-[2-chloro-4-(4-chlorophenoxy) phenyl]-2-hydroxy-3-(1, 2, 4-triazol-1-yl) propionate or (II) 2-[2-chloro-4-(4-chlorophenoxy) phenyl]-2-hydroxy-3-(1, 2, 4-triazol-1-yl) propionic acid.
Owner:BASF SE

In vivo intra-airway vector-free epigenetic editing

Disclosed are methods and compositions for gene-specific epigenetic editing involving contacting a gene or gene promoter with a gene-specific fusion complex containing a DNA demethylase enzyme. The methods include demethylating one or more nucleotides within the gene, promoter, or anticipated regulatory region, resulting in epigenetic editing of the gene, nucleotides, regulatory motif, or promoter. This demethylation process serves to test the mechanistic significance of gene demethylation or enhance the transcriptional responsiveness of the gene.
Owner:RHODE ISLAND HOSPITAL

Use of ALKBH5 as a target in the preparation of a medicament for inhibiting progression of tmbc and medicament

PendingCN122461502APharmaceutical SubstancesTumor differentiation
This invention relates to the application of ALKBH5 as a target in the preparation of drugs for inhibiting the progression of TNBC, and to the drugs themselves. This application discovers mRNA m 6 The alpha-modifying demethylase ALKBH5 is specifically highly expressed in triple-negative breast cancer (TNC). Using spontaneous TNC models and xenograft tumor models, knockout or knockdown of ALKBH5 significantly inhibited breast hyperplasia and the development of TNC, and promoted tumor differentiation. Simultaneously, the specific inhibitor EN300-14040 of ALKBH5 significantly inhibited the growth of TNC organoids, promoted TNC cell differentiation, and enhanced the sensitivity of TNC organoids to the endocrine drug 4OH-T, exhibiting a synergistic inhibitory effect with 4OH-T. Therefore, ALKBH5 represents a potential novel therapeutic target for TNC, and ALKBH5 inhibitors are a potential new type of drug for the treatment of TNC.
Owner:HANGZHOU INST FOR ADVANCED STUDY UCAS

Development of lysine-specific demethylase 1 (LSD1) inhibitors as Anti-cancer reagents

The present disclosure is concerned with substituted cyclopropyl carbamate and cyclopropyl sulfonamide compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds in the treatment of various cancers such as, for example, cancers comprising cells that express at least one Sox 2 stem cell marker. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Owner:BOARD OF RGT NEVADA SYST OF HIGHER EDUCATION ON BEHALF OF THE UNIV OF NEVADA RENO

Plants with increased yield, biomass and stress tolerance

The present invention relates to a transgenic plant having increased biomass, yield, and / or abiotic stress tolerance. In particular, the present invention relates to a transgenic plant or plant cell into which a nucleic acid molecule encoding an RNA demethylase FTO (fat mass associated with obesity) protein is introduced. The present disclosure also provides methods of producing plants having increased biomass, yield, and / or abiotic stress tolerance.
Owner:AVNER CORP

Plants having increased yield, biomass, and stress tolerance

PCT designated stage expiredWO2024211438A3BiocideClimate change adaptationPlant cellTransgene
The present invention is directed towards a transgenic plant that has an increased biomass, yield and / or abiotic stress tolerance. In particular, the present invention is directed to a transgenic plant or plant cell in which a nucleic acid molecule encoding an RNA demethylase FTO (fat mass and obesity-associated) protein is introduced. Also provided by the disclosure are methods of producing the plants with increased biomass, yield and / or abiotic stress tolerance.
Owner:AFERNA INC

A m based on dCasRx-FTO 6 A editing system and its recombinant expression plasmids, cell models and their applications

This invention belongs to the field of gene editing and epigenetics technology, and discloses a method based on dCasRx-FTO for m 6 A. Editing system and its recombinant expression plasmid, cell model and its application; this invention first constructs an m based on dCasRx-FTO. 6 The A-editing system, namely the dCasRx-FTO fusion protein, utilizes catalytically inactivated CasRx (dCasRx) as a highly specific RNA guidance scaffold to fuse with m 6 A demethylase FTO enables the targeting of a specific region m 6 Targeted removal of A-modification. Building upon this, the present invention further obtains monoclonal mouse embryonic stem cells (mESCs) stably expressing the dCasRx-FTO fusion protein. Combined with an sgRNA library targeting a specific set of transcripts, high-throughput screening can be performed on embryonic stem cells containing the 2C-like pluripotency reporter gene MERVL::tdTomato, thereby identifying key m-modification inhibitors suppressing the pluripotency state of mESCs at the transcriptome level. 6 A modification site, thus enabling its use to reveal m 6 The key role of A-modified targets in the regulation of stem cell pluripotency.
Owner:CHINA PHARM UNIV

Bacterial N-demthylases as biocatalysts for the production of methylxanthines

ActiveUS12448633B2BacteriaOxidoreductasesMethyl xanthineXanthine
The present disclosure relates to mutant enzymes and bacterial strains constructed to produce paraxanthine and 7-methylxanthine from caffeine and methods for the manufacture and use thereof.
Owner:UNIVERSITY OF ALABAMA

Transgenic plant and the method for producing the same

The present invention is directed to a transgenic plant and a method for producing the same. In particular, the present invention is directed to a transgenic plant or a plant cell in which a nucleic acid molecule encoding an m6A demethylase is introduced, wherein said m6A demethylase has the following two domains: i) N-terminal domain (NTD) having the function of AlkB oxidation demethylase; and ii) C-terminal domain (CTD). The present invention is also directed to a method for producing said plant, comprising introducing a nucleic acid molecule encoding an m6A demethylase into a regenarable plant cell, and regenerating a transgenic plant from the regenerable plant cell.
Owner:EPIPLANTA BIOTECH LTD

Compositions and methods for minimizing nornicotine synthesis in tobacco

Compositions and methods for reducing the level of nornicotine and N′-nitrosonornicotine (NNN) in tobacco plants and plant parts thereof are provided. The compositions comprise isolated polynucleotides and polypeptides for a root-specific nicotine demethylases, CYP82E10, and variants thereof, that are involved in the metabolic conversion of nicotine to nornicotine in these plants. Compositions of the invention also include tobacco plants, or plant parts thereof, comprising a mutation in a gene encoding a CYP82E10 nicotine demethylase, wherein the mutation results in reduced expression or function of the CYP82E10 nicotine demethylase. Seed of these tobacco plants, or progeny thereof, and tobacco products prepared from the tobacco plants of the invention, or from plant parts or progeny thereof, are also provided. Methods for reducing the level of nornicotine, or reducing the rate of conversion of nicotine to nornicotine, in a tobacco plant, or plant part thereof are also provided. The methods comprise introducing into the genome of a tobacco plant a mutation within at least one allele of each of at least three nicotine demethylase genes, wherein the mutation reduces expression of the nicotine demethylase gene, and wherein a first of these nicotine demethylase genes encodes a root-specific nicotine demethylase involved in the metabolic conversion of nicotine to nornicotine in a tobacco plant or a plant part thereof. The methods find use in the production of tobacco products that have reduced levels of nornicotine and its carcinogenic metabolite, NNN, and thus reduced carcinogenic potential for individuals consuming these tobacco products or exposed to secondary smoke derived from these products.
Owner:NORTH CAROLINA STATE UNIV

Methods for producing lysine-specific demethylase 1 (LSD1) inhibitors

To provide a production method of lysine-specific demethylase (LSD1) inhibitors that is easier to implement and has higher yields.SOLUTION: A method for producing a compound represented by formula (I) or a pharmaceutically acceptable salt thereof comprises the step of converting a compound C to a compound D in a solvent under the action of an oxidizing agent.SELECTED DRAWING: None
Owner:JIANGSU LIANHUAN PHARMA +1

Ultrasonic sensitization nanometer material based on MOFs and preparation method and application of ultrasonic sensitization nanometer material

The invention discloses an ultrasonic sensitized nano material based on MOFs (Metal-Organic Frameworks) as well as a preparation method and application thereof, and belongs to the technical field of biological materials. Comprising drug-loaded MOFs; the MOFs is selected from the group consisting of UiO-66-NH2; the UiO-66-NH2 is a particle formed by connecting an amino functional group to UiO-66; an m6A-mRNA (Messenger Ribonucleic Acid) demethylase inhibitor compound is loaded in the medicine carrying MOFs; the m6A-mRNA demethylase inhibitor compound is formed by coordination of a Rhein molecule and a bivalent copper ion; the outer surface of the drug-loaded MOFs is combined with an anti-CD19 antibody; and the outer surface of the drug-loaded MOFs is also modified with mPEG-PO3 (mPEG (Polyethylene Glycol)-PO3). As a replacement therapy of BCL, the MOFs-based ultrasonic sensitized nanomaterial can specifically gather in BCL tissues to play a therapeutic role after being functionalized by mPEG-PO3 and an anti-CD19 antibody.
Owner:JILIN UNIVERSITY

Photoenzyme catalytic reaction for producing methane through oxygen demethylation of aryl methyl ether and application of photoenzyme catalytic reaction

The invention relates to a photo-enzyme catalytic reaction for producing methane through oxygen demethylation of aryl methyl ether and application of the photo-enzyme catalytic reaction. According to the method, demethylase MTase I and cobalamine binding protein CP which are purified by a nickel column are utilized, the demethylase MTase I, the cobalamine binding protein CP and 5-denitrified riboflavin react with different aryl methyl ether substrates respectively in a buffer solution with the pH value of 6.5 under the conditions of purple light irradiation and anaerobic conditions, O-demethylation of aryl methyl ether is catalyzed, and the 5-denitrified riboflavin is obtained. Demethylation products of methane and phenols are generated; according to the method disclosed by the invention, demethylation methane production reaction is completed, and meanwhile, the reaction efficiency and the substrate spectrum of oxygen demethylation of aryl methyl ether are improved. In-vitro catalysis of the demethylation methane production reaction of flavone aryl ether and natural biomass lignin alkaline hydrolysate is realized for the first time, and compared with the current demethylation reaction, the method has the advantages of mild reaction conditions, environmental protection and the like, and meanwhile, the removed methyl is converted into methane, so that the method is suitable for industrial production. The addition of additional methyl acceptors and the generation of byproducts are effectively avoided, and the atom economy is improved.
Owner:TIANJIN UNIV

siRNA targeting and inhibiting the expression of demethylase ALKB-1 gene or ALKBH1 gene and its application

The present invention belongs to the field of biomedical technology, and specifically relates to siRNA that targets and inhibits the expression of the demethylase ALKB-1 gene or ALKBH1 gene and its application. The present invention uses Caenorhabditis elegans as a model, designs and synthesizes highly specific targeted siRNA for ALKB-1, and delivers it into the nematode body to achieve specific knockdown of ALKB-1, significantly delaying the aging process of Caenorhabditis elegans, and also has an improvement effect on aging-related diseases including Parkinson's. Through mechanism analysis, it was found that the anti-aging effect of specific siRNA targeted intervention of ALKB-1 is achieved by regulating the methylation modification of tRNA to affect protein homeostasis. The present invention provides a new reference method for the development of anti-aging drugs and gene therapy strategies based on siRNA targeted knockdown technology to intervene in the function of ALKB-1.
Owner:JINAN UNIVERSITY

DsRNA pesticide targeting ustilaginoidea virens and application

The invention discloses a chimera dsRNA (double-stranded ribonucleic acid). The chimera dsRNA comprises an efficient silencing segment in a Ustilaginoidea virens cytochrome P450 sterol 14 alpha-demethylase UvCYP51 gene, an efficient silencing segment in a Ustilaginoidea virens transcription factor UvbZIP11 gene and an efficient silencing segment in a Ustilaginoidea virens apoptosis related gene UvBI-1 gene. The invention also discloses a preparation method of the chimera dsRNA. The invention also discloses application of the chimera dsRNA in prevention and treatment of false smut. The invention also discloses a use method of the chimera dsRNA, and the chimera dsRNA can be prepared into a nucleic acid pesticide which acts on rice panicles and is used for preventing and treating false smut.
Owner:HUAZHONG AGRI UNIV

Pyocyanine demethylases and related phenazine degrading agents compositions, methods and systems for interfering with viability of bacteria

Provided herein are engineered pyocyanin demethylases having replacements in in positions A53, I73, A87, T91, M99, A129 and K141 of pyocyanin demethylase PodA of SEQ ID NO: 1 or a derivative thereof and related phenazine degrading agents, compositions, methods and systems, as well as a combined administration of one or more pyocyanin demethylases and antibiotics and / or antibiotics resulting in a synergic inhibition of viability of phenazine producing bacteria, and related phenazine degrading agents, compositions, methods and systems.
Owner:YEDA RES & DEV CO LTD +1

BZIP transcription factors regulate conversion of nicotine to nornicotine

A method of decreasing conversion of nicotine to nornicotine is provided herein. The methods includes administering at least one basic region / leucine zipper (bZIP) type transcription factor inhibitor to an organism in need thereof. Also provided herein is a method of decreasing conversion of nicotine to nornicotine including mutating a bZIP type transcription factor binding site on a promoter of a nicotine N-demethylase (NND). Further provided herein is a method of decreasing conversion of nicotine to nornicotine including mutating a plant genome to knockout at least one bZIP type transcription factor.
Owner:R J REYNOLDS TOBACCO COMPANY +1

M6A demethylase ALKBH1 small-molecule inhibitor, synthetic method and application

The invention discloses an m6A demethylase ALKBH1 small-molecule inhibitor as well as a synthesis method and application thereof, and relates to the technical field of pharmacy, and the m6A demethylase ALKBH1 small-molecule inhibitor has a chemical structural formula as shown in a formula (I). The m6A demethylase ALKBH1 small-molecule inhibitor has biological activity, can be combined with ALKBH1 protein in vitro in a dose-dependent manner, reduces ALKBH1 enzyme activity and has nano-friction-level inhibition activity, and meanwhile, the effect of the small-molecule inhibitor on lung cancer cells A549 is verified, so that the m6A demethylase ALKBH1 small-molecule inhibitor has a good application prospect. A wide application prospect is provided for subsequent computer simulation screening, accurate synthesis of the m6A demethylase ALKBH1 small-molecule inhibitor and application of the m6A demethylase ALKBH1 small-molecule inhibitor in resisting diseases caused by ALKBH1 overexpression. # imgabs0 #
Owner:HENAN UNIVERSITY

Modified RNA demethylase and encoding nucleic acid thereof, use thereof, plant cultivation method and product

PCT designated stage expiredWO2025044469A1OxidoreductasesFermentationPlant traitsPlant cultivation
Provided are a modified RNA demethylase, a nucleic acid encoding the modified RNA demethylase, the use thereof, a plant cultivation method, and a product. Compared with an original RNA demethylase derived from algae or invertebrates, the modified RNA demethylase is obtained by means of adding a specific peptide fragment sequence at the N-terminus or C-terminus of the original RNA demethylase. The modified RNA demethylase or the nucleic acid encoding the modified RNA demethylase is introduced into an initial plant to obtain a target plant having optimized traits compared with the initial plant.
Owner:EPIPLANTA BIOTECH LTD

A mefenoxam-ipconazole combined seed treatment agent, preparation method and use thereof

This invention discloses a compound seed treatment agent containing metalaxyl-M and tebuconazole, its preparation method, and its uses, belonging to the technical field of seed treatment agents. The suspension of this invention uses metalaxyl-M, tebuconazole, and sodium selenite as the main components, supplemented with emulsifying and dispersing agents, wetting and dispersing agents, antifreeze agents, suspending agents, film-forming agents, and warning colors, and is prepared by adding deionized water to a sufficient volume. Metalaxyl-M targets and inhibits ribosomal RNA polymerase I of oomycete pathogens, while tebuconazole targets and inhibits sterol 14α-demethylase. The two have complementary fungicidal spectra, synergistically controlling maize stalk rot and maize head smut. Sodium selenite, by inhibiting the oxidative stress defense system of pathogenic fungi involving glutathione and thioredoxin, promotes the effects of the two main components and simultaneously remediates selenium-deficient soils. This invention is suitable for the green and efficient control of maize stalk rot and head smut, and also has the function of ecological restoration of selenium-deficient soils.
Owner:BENXI ZHUANGMIAO AGROCHEM TECH & DEV

Genetically modified host cells producing benzylisoquinoline alkaloids

PendingAU2020363960B2BiotechnologyBenzyl group
The invention relate to genetically modified hosts cell comprising a pathway having enhanced production of one or more benzylisoquinoline alkaloids wherein the cell expresses heterologous insect genes encoding insect demethylases converting thebaine into northebaine, thebaine into oripavine, thebaine into nororipavine and / or oripavine into nororipavine.
Owner:RIVER STONE BIOTECH APS

A specific super-resolution fluorescent probe for lysine-specific demethylase 1 and its application

A specific super-resolution fluorescent probe for lysine-specific demethylase 1 and its application relate to the field of molecular probes. The present invention designs and synthesizes a specific small molecule fluorescent probe LP1 for lysine-specific demethylase 1. The probe is designed based on the active cavity configuration of lysine-specific demethylase 1 and the molecular structure of its specific inhibitor, and has excellent light stability, pH stability, and anti-interference ability against intracellular ions and amino acids. The product released after the probe LP1 reacts with lysine-specific demethylase 1 has an excellent near-infrared fluorescence signal. The probe LP1 successfully and specifically detects the activity of lysine-specific demethylase 1 in different biological samples (pure protein, cell lysate, living cells) and detects the subcellular organelle localization of lysine-specific demethylase 1.
Owner:XIAMEN UNIV

Experimental device and method for adjusting FTO based on GLP-1

The invention discloses a GLP-1-based FTO adjustment experiment device, which comprises two pieces of I-shaped steel, the upper ends of the two pieces of I-shaped steel are fixedly provided with a first fixing frame, a second fixing frame and a third fixing frame at equal intervals, and the first fixing frame is provided with a filter box; the method for adjusting the FTO experimental device based on the GLP-1 comprises the following steps: selecting 6-8-week-old mice, feeding the mice with high-fat diet for 12 weeks, establishing an atherosclerosis model, obtaining required animal tissues after the mice are killed, and carrying out subsequent experiments. The specific mechanism that GLP-1 regulates demethylase FTO to change the m6A methylation level of a differential gene so as to delay the atherosclerosis progress is deeply explored, an epigenetic regulation mechanism in the occurrence and development process of cardiovascular diseases is revealed, and a new theoretical basis is provided for research of the cardiovascular diseases; the field and thought of cardiovascular disease research are expanded, a new theoretical basis is provided for prevention and treatment of cardiovascular diseases, and the morbidity and mortality of the cardiovascular diseases can be reduced.
Owner:SHANXI MEDICAL UNIV